Issued Patents All Time
Showing 51–75 of 80 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7749530 | Kinase inhibitors | Lon T. Spada, Jane-Guo Shiah, Patrick M. Hughes, Gerald W. DeVries, Jeffrey L. Edelman +2 more | 2010-07-06 |
| 7728034 | Treating neurological disorders using selective antagonists of persistent sodium current | George R. Ehring, Joseph S. Adorante, Larry A. Wheeler, Scott M. Whitcup | 2010-06-01 |
| 7705055 | Treating neurological disorders using selective antagonists of persistent sodium current | George R. Ehring, Joseph S. Adorante, Larry A. Wheeler, Scott M. Whitcup | 2010-04-27 |
| 7531665 | Kinase inhibitors for the treatment of disease | Steven W. Andrews, Michael E. Garst, Xialing Guo, Jonathan J. Hebert, Julie A. Wurster +1 more | 2009-05-12 |
| 7414054 | 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors | Steven W. Andrews, Julie A. Wurster, Edward Wang | 2008-08-19 |
| 7294716 | Process for preparing isomerically pure prodrugs of proton pump inhibitors | Michael E. Garst, Lloyd J. Dolby, Shervin Esfandiari, Vivian R. MacKenzie, Alfred A. Avey +2 more | 2007-11-13 |
| 7125908 | Treating pain using selective antagonists of persistent sodium current | George R. Ehring, Joseph S. Adorante, John E. Donello, Larry A. Wheeler | 2006-10-24 |
| 7060723 | Treating neurological disorders using selective antagonists of persistent sodium current | George R. Ehring, Joseph S. Adorante, Larry A. Wheeler, Scott M. Whitcup | 2006-06-13 |
| 7060844 | (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Steven W. Andrews, Xialing Guo, Zhen Zhu, Clarence Eugene Hull, III, Julie A. Wurster +2 more | 2006-06-13 |
| 7015220 | 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors | Steven W. Andrews, Julie A. Wurster, Edward Wang | 2006-03-21 |
| 6765012 | 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Steven W. Andrews, Julie A. Wurster, Edward Wang | 2004-07-20 |
| 6747025 | Kinase inhibitors for the treatment of disease | Steven W. Andrews, Michael E. Garst, Xialing Guo, Jonathan J. Hebert, Julie A. Wurster +1 more | 2004-06-08 |
| 6703391 | Quinoxalinedione derivatives, their preparation and use | Christopher Franklin Bigge, Frank Watjen | 2004-03-09 |
| 6541504 | (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | Steven W. Andrews, Julie A. Wurster, Clarence Eugene Hull, III, Edward Wang, Xialing Guo +1 more | 2003-04-01 |
| 6458781 | Substituted diarylalkyl amides as calcium channel antagonists | David T. Connor, Lain-Yen Hu, Michael Francis Rafferty, Bruce D. Roth, Todd Robert Ryder +2 more | 2002-10-01 |
| 6423689 | Peptidyl calcium channel blockers | Richard John Booth, Louis Brogley, Wayne L. Cody, David T. Connor, Harriet W. Hamilton +10 more | 2002-07-23 |
| 6197771 | Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinediones | Christopher Franklin Bigge, Robert Schelkun, Chung Stephen Yi | 2001-03-06 |
| 6124280 | Substituted phenols as novel calcium channel blockers | Robert Schelkun, Po-Wai Yuen | 2000-09-26 |
| 6117841 | Substituted peptidylamine calcium channel blockers | Lain-Yen Hu, Laszlo Nadasdi, Michael Francis Rafferty, Todd Robert Ryder, Diego Silva +3 more | 2000-09-12 |
| 6057313 | Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinediones | Christopher Franklin Bigge, Robert Schelkun, Chung Stephen Yi | 2000-05-02 |
| 5245028 | Process for preparing tetracyclic amines useful as cerebrovascular agents | — | 1993-09-14 |
| 5238958 | Substituted .alpha.-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals | Graham Johnson, Perry M. Novak | 1993-08-24 |
| 5145845 | Substituted 2-carboxylindoles having pharmaceutical activity | Graham Johnson, Po-Wai Yuen | 1992-09-08 |
| 5141934 | Tetracyclic amines having pharmaceutical activity | Graham Johnson | 1992-08-25 |
| 5109136 | Tetracyclic amines useful as cerebrovascular agents | — | 1992-04-28 |